ARGNF:OTCMKTS
argenx SE
$790.15
0.00%
(0.00) 1D
Oct 13, 10:39:58 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGNF...
Mkt. cap
52.16B
Avg. vol.
14.00
Volume
0.00
52-wk high
$1,020.00
52-wk low
$708.72
Beta
0.46
Shares outstanding
62.89M
No. of employees
2K
Mkt. cap
52.16B
Avg. vol.
14.00
Volume
0.00
52-wk high
$1,020.00
52-wk low
$708.72
Beta
0.46
Shares outstanding
62.89M
No. of employees
2K
News stories
From web sources and news partners
ad-hoc-news.de
·
1 hour ago
Goldman lifts target for Argenx stock to EUR 959.00
Yahoo Finance
·
2 hours ago
Zacks Investment Ideas feature highlights: Cummins, Argenx and PACCAR
ad-hoc-news.de
·
5 hours ago
argenx sets October 22 results date as Argenx stock costs EUR 761.20
ad-hoc-news.de
·
8 hours ago
argenx schedules third-quarter results for October 22: stock pre-market at EUR 756.30
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE